ArticleFrontiers in public health2026
Activating laboratory surveillance response to the threat of H5N1 influenza in the Veterans Health Administration, 2024-25.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Veterans Health Administration (VHA) mobilized and adapted its established national infrastructure to enhance influenza surveillance during 2024-2025 highly pathogenic avian influenza (HPAI) A(H5N1) panzootic. Additionally, VHA's Public Health Reference Laboratory (PHRL) expanded capacity for H5 subtyping and whole genome sequencing (WGS) to support detection. Methods: Routine influenza surveillance was enhanced with customized queries to identify cases in high-risk counties with reported H5N1 detected in animals. In coordination with VHA clinical laboratories, select samples were sent to PHRL. PHRL subtyped specimens received, which included hospitalized cases. Demographics of influenza A cases in VHA were compared with those residing in high-risk "surveilled" counties (with reported H5N1 detection in animals) and those whose specimens were sent to PHRL for H5 subtyping. Results: From 4/1/2024-5/31/2025, we identified 40,406 positive influenza A VHA cases (12.5% with local subtyping performed), including 5,348 cases from "surveilled" counties. A total of 1,155 specimens were received by PHRL for H5 subtyping and 180 completed WGS. Cases from "surveilled" counties had fewer females, fewer in 50-69 age group and more of Hispanic ethnicity compared to other influenza A cases. No H5N1 was detected. Conclusion: We highlight the complexity and resources necessary for epidemiologic and laboratory surveillance of H5N1 within a large, national health system during a recognized panzootic. Additional resources for decentralized influenza A subtyping at local VA clinical laboratories are needed as centralized subtyping and WGS at PHRL was not comprehensive. Although H5 influenza has not yet been observed among Veterans within VHA, the ongoing risk warrants continued vigilance and monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.